57
Participants
Start Date
July 9, 2014
Primary Completion Date
June 27, 2016
Study Completion Date
December 31, 2027
Abiraterone Acetate
Administered orally (by mouth) once daily in morning at a dose of 1000 mg for up to the end of treatment (EoT) visit (ie, for up to approximately 18 months).
Prednisone
Administered orally twice a day at a dose of 5mg for up to the end of treatment (EoT) visit (ie, for up to approximately 18 months).
JNJ-56021927
Administered orally once daily in morning at a dose of 240 mg starting on Day 8, Treatment Cycle 1 for up to the end of treatment (EoT) visit (ie, for up to approximately 18 months).
Los Angeles
San Francisco
Houston
Vancouver
Montreal
Rotterdam
Sutton
Lead Sponsor
Aragon Pharmaceuticals, Inc.
INDUSTRY